Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans

Abstract

Compared to best-in-class GLP-1 mono-agonists, unimolecular co-agonists of GLP-1 and GIP with optimized pharmacokinetics enhance glycemic and metabolic benefits in mammals.

Overview

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.3007218

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

11 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 44 references

Cited by

See all 702

Metadata

Authors
Finan, B., Ma, T., Ottaway, N., Müller, T. D., Habegger, K. M., Heppner, K. M., Kirchner, H., Holland, J., Hembree, J., Raver, C., Lockie, S. H., Smiley, D. L., Gelfanov, V., Yang, B., Hofmann, S., Bruemmer, D., Drucker, D. J., Pfluger, P. T., Perez-Tilve, D., Gidda, J., Vignati, L., Zhang, L., Hauptman, J. B., Lau, M., Brecheisen, M., Uhles, S., Riboulet, W., Hainaut, E., Sebokova, E., Conde-Knape, K., Konkar, A., DiMarchi, R. D., & Tschöp, M. H.
Affiliations
  • Helmholtz Munich (DE)
  • Indiana University Bloomington (US)
  • University of Cincinnati (US)
  • Karolinska Institutet (SE)
  • Monash University (AU)
  • Technical University of Munich (DE)
  • University of Kentucky (US)
  • Mount Sinai Hospital (CA)
  • Metabolic Diseases Institute, Division of Endocrinology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45237, USA.
  • Marcadia Biotech, Carmel, IN 46032, USA.
  • F. Hoffmann-La Roche AG (CH)
  • F. Hoffmann–La Roche Ltd., Basel 4070, Switzerland.
Corresponding author
  • Finan, Brian
  • Ma, Tao
  • DiMarchi, Richard D.
  • Tschöp, Matthias H.
Venue
Science Translational Medicine
Published
2013-10-30
Volume
5
Issue
209
Pages
209ra151-209ra151
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W2149717292
Cited by
696
References
44
Citations by year
2026: 46 · 2025: 56 · 2024: 91 · 2023: 71 · 2022: 54 · 2021: 64 · 2020: 56 · 2019: 63 · 2018: 50 · 2017: 40 · 2016: 43 · 2015: 36 · 2014: 22 · 2013: 4
FWCI
27.53
Type
journal article
Language
en
Open access
closed
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • mediaTUM (Technical University of Munich) (submittedVersion)
  • Site cant be reached (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, obesity, type 2 diabetes, insulin resistance, fat mass reduction, PEGylation, lipid modification, pharmacokinetics, impaired glucose tolerance, db/db mice, Zucker diabetic fatty rats, Macaca fascicularis, gastrointestinal adverse effects
MeSH terms
Glucagon-Like Peptide-1 Receptor, Liraglutide, Exenatide, Acylation, Adolescent, Adult, Aged, Animals, Haplorhini, Diabetes Mellitus, Type 2, Female, Gastric Inhibitory Polypeptide, Glucose Tolerance Test, Humans, Hyperglycemia, Insulin, Male, Middle Aged, Peptides, Receptors, Gastrointestinal Hormone, Rodentia, Venoms, Weight Loss, Treatment Outcome, Receptors, Glucagon, Mice, Rats, Glucagon-Like Peptide 1, Incretins, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans. https://app.cochat.ai/papers/10.1126/scitranslmed.3007218
The paper
Finan, B., Ma, T., Ottaway, N., Müller, T. D., Habegger, K. M., Heppner, K. M., Kirchner, H., Holland, J., Hembree, J., Raver, C., Lockie, S. H., Smiley, D. L., Gelfanov, V., Yang, B., Hofmann, S., Bruemmer, D., Drucker, D. J., Pfluger, P. T., Perez-Tilve, D., . . . Tschöp, M. H. (2013). Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.3007218

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.